Wounds and Injuries clinical trials at UC Davis
1 research study open to eligible people
open to eligible people ages up to 17 years
Trauma is the leading cause of death and disability in children in the United States. The long-term goal of this project is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children. This is a 40-patient pilot study to evaluate the feasibility of two subsequent large-scale studies of TXA in injured children.
Sacramento, California and other locations
Our lead scientists for Wounds and Injuries research studies include Daniel K Nishijima, MD, MAS.